The ongoing Early Prostate Cancer (EPC) programme is investigating the effects of adding bicalutamide 150 mg/day to standard care (radiotherapy, radical prostatectomy or watchful waiting). This study ...

Treatment with Xtandi reduced the risk of progression by 76 percent compared with bicalutamide in men with castration-resistant prostate cancer, according to topline results from the phase 2 STRIVE ...

Combined modality therapy for stage II and stage III pancreatic carcinoma. Patients with progressive prostate cancer were treated with bicalutamide 200 mg daily. Before treatment, patients' tumors ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — The addition of bicalutamide to radiation therapy significantly improved OS and freedom from ...

Cytokines in Metastatic Renal Cell Carcinoma: Is It Useful to Switch to Interleukin-2 or Interferon After Failure of a First Treatment? PURPOSE: To compare the efficacy of bicalutamide monotherapy to ...

This medication is a non-steroidal anti-androgen, prescribed for prostate cancer.

Learn everything you need to know about Bicalutamide-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

Salvage radiation therapy is often necessary in men who have undergone radical prostatectomy and have evidence of prostate-cancer recurrence signaled by a persistently or recurrently elevated prostate ...

(HealthDay News) — When prostate cancer recurs after surgery, treatment with both radiation and bicalutamide can extend some men’s lives, according to a study published in the Feb. 2 issue of New ...

Please provide your email address to receive an email when new articles are posted on . The oral androgen receptor inhibitor enzalutamide significantly reduced the risk for prostate cancer progression ...